Source link : https://www.newshealth.biz/health-news/psilocybin-bests-ssri-for-mdd-in-first-long-term-comparison/
MILAN — Psilocybin is associated with a better overall outcome in the treatment of moderate to severe major depressive disorder (MDD) than with the selective serotonin reuptake inhibitor (SSRI) escitalopram, results of the first long-term comparison of the two treatments suggest. “This is the first work to compare the long-term effects of these two drugs […]
Author : News Health
Publish date : 2024-09-23 05:59:12
Copyright for syndicated content belongs to the linked Source.